IFN-β exerts its anti-inflammatory effect through the suppression of NLRP1 and NLRP3 inflammasome and IL-1β production, as it was shown in mouse bone marrow-derived macrophages and blood monocytes isolated from IFN-β treated MS patients (173). Here, NLRP3 is linked to myeloid sarcoma.